Can Protein Interactions be Targeted for Therapeutic Purposes?
Yes, targeting protein interactions is a promising approach in therapeutic development. Small molecules, peptides, and antibodies can be designed to disrupt or stabilize specific protein interactions. For instance, monoclonal antibodies are used in cancer therapy to target specific protein interactions involved in tumor growth and survival.
